Microbial Sensitivity Tests

"Microbial Sensitivity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).

Descriptor ID	D008826
MeSH Number(s)	E01.370.225.875.595 E05.200.875.595 E05.337.550.400
Concept/Terms	Microbial Sensitivity Tests Microbial Sensitivity Tests Microbial Sensitivity Test Sensitivity Test, Microbial Sensitivity Tests, Microbial Test, Microbial Sensitivity Tests, Microbial Sensitivity Drug Sensitivity Assay, Microbial Antimicrobial Susceptibility Breakpoint Determination Antimicrobial Susceptibility Breakpoint Determination Breakpoint Determination, Antimicrobial Susceptibility Virus Drug Sensitivity Tests Virus Drug Sensitivity Tests Viral Drug Sensitivity Tests Breakpoint Determination, Antibacterial Susceptibility Breakpoint Determination, Antibacterial Susceptibility Antibacterial Susceptibility Breakpoint Determination Fungus Drug Sensitivity Tests Fungus Drug Sensitivity Tests Fungal Drug Sensitivity Tests Minimum Inhibitory Concentration Minimum Inhibitory Concentration Concentration, Minimum Inhibitory Concentrations, Minimum Inhibitory Inhibitory Concentration, Minimum Inhibitory Concentrations, Minimum Minimum Inhibitory Concentrations Antibiogram Antibiogram Antibiograms Bacterial Sensitivity Tests Bacterial Sensitivity Tests Tests, Bacterial Sensitivity Sensitivity Tests, Bacterial Test, Bacterial Sensitivity Bacterial Sensitivity Test Sensitivity Test, Bacterial

Below are MeSH descriptors whose meaning is more general than "Microbial Sensitivity Tests".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Clinical Laboratory Techniques [E01.370.225]
Microbiological Techniques [E01.370.225.875]
Microbial Sensitivity Tests [E01.370.225.875.595]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Microbiological Techniques [E05.200.875]
Microbial Sensitivity Tests [E05.200.875.595]
Evaluation Studies as Topic [E05.337]
Drug Evaluation, Preclinical [E05.337.550]
Microbial Sensitivity Tests [E05.337.550.400]

Below are MeSH descriptors whose meaning is related to "Microbial Sensitivity Tests".

Below are MeSH descriptors whose meaning is more specific than "Microbial Sensitivity Tests".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Microbial Sensitivity Tests" by people in this website by year, and whether "Microbial Sensitivity Tests" was a major or minor topic of these publications.

Bar chart showing 53 publications over 19 distinct years, with a maximum of 8 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2002	0	2	2
2003	0	1	1
2004	0	5	5
2005	0	3	3
2006	0	4	4
2007	0	6	6
2008	0	1	1
2009	0	1	1
2010	0	6	6
2011	0	3	3
2012	0	8	8
2013	2	2	4
2014	0	2	2
2015	0	1	1
2016	0	2	2
2018	0	1	1
2019	0	1	1
2022	0	1	1

Below are the most recent publications written about "Microbial Sensitivity Tests" by people in Profiles.

Aragaw WW, Cotroneo N, Stokes S, Pucci M, Critchley I, Gengenbacher M, Dick T. In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus. Microbiol Spectr. 2022 02 23; 10(1):e0132121.

View in: PubMed
Al Rahmany D, Albeloushi A, Alreesi I, Alzaabi A, Alreesi M, Pontiggia L, Ghazi IM. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program. Int J Infect Dis. 2019 Jun; 83:77-82.

View in: PubMed
Diphoko T, Gaseitsiwe S, Kasvosve I, Moyo S, Okatch H, Musonda R, Wainberg M, Makhema J, Marlink R, Novitsky V, Essex M. Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana. AIDS Res Hum Retroviruses. 2018 08; 34(8):667-671.

View in: PubMed
El-Shesheny R, Bagato O, Kandeil A, Mostafa A, Mahmoud SH, Hassanneen HM, Webby RJ, Ali MA, Kayali G. Re-emergence of amantadine-resistant variants among highly pathogenic avian influenza H5N1 viruses in Egypt. Infect Genet Evol. 2016 12; 46:102-109.

View in: PubMed
Jindal N, Malhotra R, Grover P, Singh S, Bansal R, Kaur S. Methicillin resistant Staphylococcus aureus (MRSA) in Malwa region of Punjab (North-West India). Indian J Med Res. 2016 Mar; 143(3):371-2.

View in: PubMed
Schuyler JA, Mordechai E, Adelson ME, Sobel JD, Gygax SE, Hilbert DW. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis. Diagn Microbiol Infect Dis. 2016 Jan; 84(1):1-3.

View in: PubMed
Whaley SG, Caudle KE, Vermitsky JP, Chadwick SG, Toner G, Barker KS, Gygax SE, Rogers PD. UPC2A is required for high-level azole antifungal resistance in Candida glabrata. Antimicrob Agents Chemother. 2014 Aug; 58(8):4543-54.

View in: PubMed
Apiwattankul N, Flynn PM, Hayden RT, Adderson EE. Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer. J Pediatric Infect Dis Soc. 2015 Jun; 4(2):104-13.

View in: PubMed
Zhou Y, Fomovska A, Muench S, Lai BS, Mui E, McLeod R. Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo. Antimicrob Agents Chemother. 2014; 58(3):1789-92.

View in: PubMed
Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, Gudur UM, Pulluru H, Bathina P, Sundaragiri PR, Sarkar M, Kakarlapudi H, Ramasamy B, Nanjireddy P, Mohin S, Dasagi M, Datla S, Kuchipudi V, Reddy S, Shahani S, Upputuri V, Marrey S, Gannamani V, Madhanagopal N, Annangi S, Sudha B, Muppavarapu KS, Moshos JA, Lephart PR, Pogue JM, Bush K, Kaye KS. Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum ß-lactamase in a large U.S. Medical Center. Antimicrob Agents Chemother. 2013 Aug; 57(8):4010-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement